NL
Nancy U. Lin
Highly rated in
10
conditions
Highly rated in
10
conditions
Check Dr. Nancy U. Lin's experience treating your condition:
About Dr. Nancy U. Lin

Nancy Lin is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Lin has been practicing medicine for over 24 years and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Breast Cancer, Metastatic Brain Tumor, HER-2 Positive Breast Cancer, Brain Tumor, and Gamma Knife Radiosurgery. She is licensed to treat patients in Massachusetts. Lin is currently accepting new patients.

Her clinical research consists of co-authoring 255 peer reviewed articles and participating in 18 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nancy U. Lin it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Nancy U. Lin accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
Locations
450 Brookline Ave, Boston, MA 02215
Background & Education
Graduate Institution
Harvard Medical School, 1999
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MA
Hospital Affiliations
Brigham And Womens Hospital
Newton-Wellesley Hospital
Dana Farber Cancer Institute
Brigham And Womens Faulkner Hospital
Languages Spoken
English
Spanish
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer
A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients With HER2-Negative Breast Cancer and Brain Metastases
A Single Arm, Open Label Phase 2 Study of Tucatinib in Combination With Trastuzumab Deruxtecan in Subjects With Previously Treated Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer
A Phase 2 Study of Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Phase I Dose-escalation Trial of ARRY-380 in Combination With Trastuzumab in Participants With Brain Metastases From HER2+ Breast Cancer
A Phase II Study of Atezolizumab in Combination With Stereotactic Radiation for Patients With Triple-negative Breast Cancer and Brain Metastasis
Feasibility and Safety of Avoiding Granulocyte Colony-stimulating Factor Prophylaxis During the Paclitaxel Portion of Dose Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen
A Phase II Study of Atezolizumab in Combination With Pertuzumab Plus High-dose Trastuzumab for the Treatment of Central Nervous System Metastases in Patients With Her2-positive Breast Cancer
A Phase II Trial of BKM120 in Patients With Triple Negative Metastatic Breast Cancer
Randomized Phase II Study of Fulvestrant With or Without Ganetespib in Patients With Hormone Receptor-Positive, Metastatic Breast Cancer
Phase II Trial of Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
A Phase I Study of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
A Phase 2 Study of ZK219477 (ZK-EPO) in Patients With Breast Cancer and Brain Metastases
View 13 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors